Your trusted destination for CME, CPD & Medical Education across the Middle East.
The 13th International Cancer & Medical Oncology Conference & Exhibition is a hybrid global conference focused on advancing cancer research, diagnostics, medical oncology, and precision oncology. It will bring together healthcare professionals, researchers, clinicians, and experts to share the latest developments through keynote talks, presentations, posters, panel discussions, and networking. 1–2 February 2027 Novotel Al Barsha, Dubai, UAE Hybrid Event 30+ scientific tracks, including Immunotherapy, Radiotherapy, Chemotherapy, Surgical Oncology, Cancer Genetics, Precision Oncology, Cancer Biomarkers, and Cancer Screening. Visit Here: https://cancer.ucgconferences.com/
Dear Colleague, Greetings from the Organizing Committee! It is our great pleasure to invite you to participate in the 13th International Cancer and Medical Oncology Conference & Exhibition (CANCERUCG 2027), taking place on February 1–2, 2027, at Novotel Al Barsha, Dubai, UAE, with both in-person and virtual participation options available. CANCERUCG 2027 will bring together leading oncologists, researchers, clinicians, healthcare professionals, academicians, and industry experts from across the globe to exchange knowledge, present innovative research, and discuss the latest advancements in cancer diagnosis, treatment, precision medicine, and emerging healthcare technologies. Why Attend? • Keynote Addresses by internationally recognized oncology experts • Scientific Sessions & Panel Discussions covering the latest research and clinical innovations • Interactive Workshops on advanced diagnostic and therapeutic approaches • Oral & Poster Presentations to showcase your research internationally • Networking Opportunities with global researchers, clinicians, and healthcare leaders • Industry Exhibition featuring innovative medical technologies, pharmaceuticals, and healthcare solutions Call for Abstracts Researchers, clinicians, and healthcare professionals are invited to submit their original research and clinical studies for oral or poster presentation. Abstract Submission: https://cancer.ucgconferences.com/submit-abstract Visa Assistance Our organizing team provides comprehensive support for registered participants, including invitation letters and guidance throughout the UAE visa application process. Experience Dubai Alongside the scientific program, participants can explore Dubai's renowned attractions and nearby landmarks, including Sheikh Zayed Grand Mosque, Louvre Abu Dhabi, Yas Island, Ferrari World Abu Dhabi, Heritage Village, and many other cultural and entertainment destinations. Conference Information Conference: 13th International Cancer and Medical Oncology Conference & Exhibition Short Name: #CANCERUCG Dates: February 1–2, 2027 Venue: Novotel Dubai Al Barsha, Dubai, UAE & Virtual Website: https://cancer.ucgconferences.com/ Registration: https://cancer.ucgconferences.com/registration Email: [email protected] WhatsApp: https://wa.me/+971551792927 Follow Us 𝕏 (Twitter/X) https://x.com/JacobDr LinkedIn https://www.linkedin.com/in/dr-priya-pujhari-683b8a226/ Facebook https://www.facebook.com/profile.php?id=100074340114419 Instagram https://www.instagram.com/cancerucg_conference/ YouTube https://www.youtube.com/@utilitarianconferencesgath3347/videos We warmly welcome you to be part of CANCERUCG 2027 and contribute to meaningful scientific discussions that are shaping the future of cancer research and oncology care. We look forward to welcoming you to Dubai for an inspiring and impactful conference. Kind regards, Organizing Committee Utilitarian Conferences Gathering
Cancer is a complex group of diseases marked by the uncontrolled growth of abnormal cells, which can invade nearby tissues and spread to distant organs through metastasis. As a major global health challenge, cancer continues to drive research and innovation in prevention, early detection, diagnosis, treatment, and personalized care.
Medical Oncology is a specialized field focused on the prevention, diagnosis, and treatment of cancer through systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. It plays a vital role in comprehensive cancer care by addressing cancer at the cellular and molecular levels and developing personalized treatment strategies to improve patient outcomes.
Immunotherapy is an innovative approach to cancer treatment that harnesses and strengthens the body’s immune system to recognize and fight cancer cells. Unlike conventional treatments that directly target cancer cells, immunotherapy enhances the immune response to identify, attack, and eliminate harmful cells, offering new possibilities for personalized and effective cancer care.
Radiotherapy, also known as radiation therapy, is a widely used cancer treatment that employs high-energy radiation to destroy cancer cells or control their growth. By damaging the DNA of cancer cells, radiotherapy prevents them from dividing and promotes their destruction while aiming to minimize exposure to surrounding healthy tissues. It plays an important role in cancer treatment, symptom control, and comprehensive oncology care.
Chemotherapy is a widely used cancer treatment that employs powerful drugs to destroy cancer cells or slow their growth and division. Because these medicines target rapidly dividing cells, they may also affect certain healthy cells, potentially causing side effects. Chemotherapy can be administered through intravenous infusion, oral medications, or injections and remains an important component of comprehensive cancer treatment and management.
Surgical Oncology is a specialized field of medicine focused on the surgical diagnosis, staging, and treatment of cancer. Surgical oncologists perform procedures to remove tumors and surrounding tissues while also managing cancer-related symptoms and complications. They work closely with medical oncologists, radiation oncologists, pathologists, and other specialists as part of a multidisciplinary approach to comprehensive cancer care.
Hormone Therapy is a treatment approach that uses hormones or hormone-blocking medications to manage hormone-related conditions and diseases. In oncology, it is particularly important in treating hormone-sensitive cancers, including breast and prostate cancer, by regulating or blocking hormones that can promote cancer growth.
Leukemia is a type of cancer that affects the blood and bone marrow, which is the soft, spongy tissue inside bones where blood cells are produced. It involves the abnormal production and accumulation of white blood cells, which crowd out normal blood cells and interfere with the body's ability to fight infection, transport oxygen, and control bleeding.
Cancer genetics is the study of genetic mutations and alterations that drive the initiation, progression, and metastasis of cancer. It focuses on understanding the roles of oncogenes, tumor suppressor genes, genomic instability, hereditary cancer syndromes, and epigenetic changes, providing insights into cancer diagnosis, prevention, and targeted therapies.
Cancer Epigenetics explores heritable changes in gene expression that occur without altering the underlying DNA sequence. These epigenetic changes can influence cellular behavior and contribute to the development, progression, and treatment response of cancer. Unlike permanent genetic mutations, many epigenetic alterations are potentially reversible, making them an important area of research for cancer diagnosis, biomarkers, prevention, and novel therapeutic strategies.
The 13th International Cancer & Medical Oncology Conference & Exhibition brings together leading oncologists, researchers, clinicians, and healthcare professionals to explore the latest advances in cancer diagnosis, treatment, and research. The conference features expert sessions, scientific presentations, networking opportunities, and discussions on emerging oncology therapies and innovations. 30 CME/CPD Credits – ACCME Accredited.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Speaker/Poster Package | Regular fee | Jan 15, 2027 | USD 299.00 |
| Delegate/Listener Package | Regular fee | Jan 15, 2027 | USD 249.00 |
| 30 CME/CPD Credits | Regular fee | Jan 15, 2027 | USD 250.00 |
| Package A(30 CME Credits) | Regular fee | Jan 15, 2027 | USD 899.00 |
| Package B(30 CME Credits) | Regular fee | Jan 15, 2027 | USD 1,099.00 |
| Student Fee (ID card required) | Regular fee | Jan 15, 2027 | USD 125.00 |
| Exhibitor | Regular fee | Jan 15, 2027 | USD 1,250.00 |
| Certificate(Mandatory) | Regular fee | Jan 15, 2027 | USD 30.00 |